A detailed history of Jump Financial, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 10,337 shares of BIO stock, worth $3.55 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,337
Previous 9,279 11.4%
Holding current value
$3.55 Million
Previous $2.53 Million 36.46%
% of portfolio
0.08%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $279,280 - $364,629
1,058 Added 11.4%
10,337 $3.46 Million
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $2.49 Million - $3.15 Million
9,279 New
9,279 $2.53 Million
Q4 2023

Oct 21, 2024

SELL
$269.37 - $365.04 $633,827 - $858,939
-2,353 Reduced 31.31%
5,163 $1.67 Million
Q4 2023

Feb 07, 2024

BUY
$269.37 - $365.04 $1.39 Million - $1.88 Million
5,163 New
5,163 $1.67 Million
Q2 2023

Oct 21, 2024

SELL
$359.49 - $486.4 $633,780 - $857,523
-1,763 Reduced 19.0%
7,516 $2.85 Million
Q2 2023

Aug 07, 2023

BUY
$359.49 - $486.4 $2.7 Million - $3.66 Million
7,516 New
7,516 $2.85 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $691,461 - $896,515
1,966 Added 18.8%
12,424 $5.23 Million
Q3 2022

Nov 07, 2022

BUY
$412.59 - $563.26 $4.15 Million - $5.66 Million
10,051 Added 2469.53%
10,458 $4.36 Million
Q2 2022

Aug 09, 2022

BUY
$463.67 - $597.16 $188,713 - $243,044
407 New
407 $202,000
Q1 2022

May 12, 2022

SELL
$524.57 - $735.42 $385,558 - $540,533
-735 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$708.84 - $794.68 $520,997 - $584,089
735 New
735 $555,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.46B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.